• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

MMA Payout

The Business of Combat Sports

  • Home
  • MMA
    • UFC
    • Bellator
    • One
    • PFL
  • Boxing
  • Legal
  • Ratings
  • Payouts
  • Attendance
  • Gate

Ferreira accepts 17-month suspension from USADA

December 21, 2016 by Jason Cruz Leave a Comment

Carlos Diego Ferreira has accepted a 17-month suspension from USADA from a failed drug test this past spring.  The 31-year-old Brazilian fighter declared the use of a product that listed and contained a prohibited substance and tested for another prohibited substance.

Ferreira tested positive for Ostarine as a result of an out of competition test on April 29, 2016.  He also listed 7-keto-DHEA on his sample paperwork.  Both are prohibited substances in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy.

The release from USADA indicates that Ferreira tested several of the supplement products he was reportedly using at the time of his positive test.  Ostarine was not listed on the product label but testing conducted on the product that listed 7-keto-DHEA also contained Ostarine.

Despite the standard two-year period of ineligibility, USADA determined that a reduction to 17-months was justified.

Payout Perspective:

This suspension might be compared with that of Lyoto Machida who took an 18-month USADA suspension.  Machida declared the use of 7-keto-DEHA on his sample collection paperwork but his suspension was reduced to 18 months.  In Ferreira’s case, he declared the use of one prohibited substance but not another.  This makes Machida’s penalty seem uneven.  It’s not known if Ferreira attempted to take his case to arbitration.  Machida did make an attempt to appeal the decision at first but then decided to accept the decrease of the suspension. Did Machida’s suspension considered when USADA decided to suspend Ferreira for 17-months?

Filed Under: Drug Testing, UFC, USADA

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Featured

Despite two big losses, TKO touts antother solid quarter

Muhammad Ali American Boxing Revival Act of 2026 introduced into Senate with minor changes

Plaintiffs file Answering Brief in Cirkunov Antitrust Appeal

Jai Opetaia files a lawsuit against IBF

Parties in Mayweather-CSI Entertainment lawsuit provide joint letter to court

Plaintiffs highlight outstanding discovery in Johnson antitrust case

Archives

MMA Payout Follow

MMAPayout
Retweet on Twitter MMA Payout Retweeted

WWE merger lawsuit settlement details disclosed in 10-Q:

"WWE's portion of the overall settlement amount is $105.0 million, which is expected to be funded by probable insurance recoveries of $75M, resulting in an expected loss of $30M"

TKO beats analyst expectations with busy Q2 period

So you are saying its a 2-for-1

boosie badazz pardon approval team @scrohto

Poop has been traded for INF prospect Pee

Retweet on Twitter MMA Payout Retweeted

TKO Group Holdings released their Q2 results. UFC revenue up $120 million compared to Q2 last year. https://investor.tkogrp.com/news/news-details/2026/TKO-Reports-Second-Quarter-2026-Results/default.aspx

#Mayweather argues that CSI has not established that "alleged difficulty collecting a possible unsecured contract judgment is a legally cognizable basis for the prelim injunction it seeks."

Load More

Copyright © 2026 · MMA Payout: The Business of Combat Sports